SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike is seeing high volatility following a quarterly earnings report that exceeded expectations but fell short of the elevated growth targets demanded by the market, leading investors to lock in profits after a massive rally. The community is actively discussing the impact of the newly announced 4-for-1 stock split and debating whether the recent dip represents a healthy consolidation or the start of a deeper valuation correction.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is trending as investors debate its potential to transition from a niche digital project into a mainstream brand through retail expansion and new product integrations. While some users express frustration over stagnant price action compared to other assets, the community remains actively divided between those highlighting its tangible revenue and 'phygital' business model and those skeptical of its long-term performance.

Direxion Shares ETF Trust - Direxion Daily Technology Bull 3X ETF

Direxion Daily Technology Bull 3X Shares

The Direxion Daily Technology Bull 3X Shares is seeing active discussion as traders analyze recent technical signals like bullish engulfing patterns and potential breakout levels to navigate its inherent volatility. Community members remain polarized, balancing long-term bullish outlooks with cautious strategies involving profit-taking, hedging against potential market cycles, and reacting to semiconductor and broader tech sector performance.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotech is trending due to heightened buyout speculation and recent disclosures regarding in-vivo CAR-T clinical data, which the community views as a critical value catalyst. While some investors remain frustrated by recent price volatility and stock performance, many are actively debating the potential for a premium acquisition, particularly given the company's strong revenue growth and strategic pipeline developments.

Lighter is a decentralized trading platform built for unmatched security and scale. It’s the first exchange to offer verifiable order matching and liquidations while delivering best-in-class performance on par with traditional exchanges.

lighter

Lighter (LIT) is seeing increased community interest driven by a significant token buyback and burn program and its role as a high-performance decentralized perpetual exchange. Investors are actively discussing its integration with Robinhood's infrastructure and the broader trend of revenue-funded token economics, while some speculate on its competitive positioning against other decentralized perpetual protocols.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Nasdaq Equity Premium Income ETF

JPMorgan Nasdaq Equity Premium Income ETF

JEPQ is drawing significant investor interest as a core holding for monthly income, with the community actively debating its performance relative to other covered-call ETFs and the long-term sustainability of its dividend yield. Discussion currently centers on balancing capital appreciation with income consistency, leading many to leverage the fund as a cornerstone for building long-term, passive wealth.

Harvest Portfolios Group Inc - Harvest Diversified High Income Shares ETF (Class A Units)

Investors are closely watching HHIS.TSX as it continues to feature prominently in portfolios focused on monthly income generation, with the community frequently discussing its role in tax-efficient strategies for Canadian investors. Discussions center on the ETF's diversified composition of underlying high-income tech holdings and its performance as a core income-producing asset during market volatility.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently trending as investors debate its long-term potential, with bulls citing its post-quantum cryptography capabilities and potential adoption in tokenized finance as reasons to accumulate at current support levels. Meanwhile, the community remains polarized, with many skeptical of its extended consolidation and historical underperformance, leading to intense discussions about whether the asset is a undervalued utility or a long-term trap.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph is currently driving heated debate as investors weigh the project's long-term utility against recent price stagnation and ongoing concerns regarding tokenomics. While some community members remain aggressively bullish, citing institutional partnerships and potential for future mass adoption, others are actively criticizing the token's performance as a disappointment and questioning the foundation's commitment to retail holders.

OpenAI

OpenAI is trending as investors debate the sustainability of its massive capital expenditure and cooling growth targets, fueled by reports of potential IPO delays and ongoing legal tensions over its partnership with Apple. The community remains divided, with many expressing skepticism over the firm's path to profitability while actively tracking its private share valuation and strategic pivots in the competitive AI landscape.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Codexis (CDXS) Q1 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Codexis (CDXS) Reports Q1 Loss, Beats Revenue Estimates

Codexis (CDXS) delivered earnings and revenue surprises of +9.09% and +1.82%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Fortrea Holdings Inc. (FTRE) Beats Q1 Earnings Estimates

Fortrea Holdings Inc. (FTRE) delivered earnings and revenue surprises of +426.32% and -0.07%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Codexis (NASDAQ:CDXS) Lowered to "Hold" Rating by Wall Street Zen

Wall Street Zen cut shares of Codexis from a "buy" rating to a "hold" rating in a research report on Sunday...

Codexis (CDXS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Codexis (CDXS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Codexis (CDXS) Projected to Post Earnings on Thursday

Codexis (NASDAQ:CDXS) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at...

Codexis (NASDAQ:CDXS) Rating Increased to Buy at Wall Street Zen

Wall Street Zen upgraded Codexis from a "hold" rating to a "buy" rating in a research note on Saturday...

Codexis (NASDAQ:CDXS) Share Price Crosses Above 200-Day Moving Average   - What's Next?

Codexis (NASDAQ:CDXS) Stock Price Crosses Above 200-Day Moving Average - What's Next...

Codexis, Inc. (NASDAQ:CDXS) Short Interest Down 35.6% in March

Codexis, Inc. (NASDAQ:CDXS - Get Free Report) saw a significant drop in short interest in March. As of March 31st, there was short interest totaling 6,938,356 shares, a drop of 35.6% from the March...

537,833 Shares in Codexis, Inc. $CDXS Purchased by Tudor Investment Corp ET AL

Tudor Investment Corp ET AL purchased a new position in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 537,833 shares of the biotechnology company's stock, va...

Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments. The Performance Enzymes segment commercializes CodeEvolver protein engineering technology platform and products in the pharmaceuticals market. The Novel Biotherapeutics segment targets new opportunities to discover and improve biotherapeutic drug candidates. Its products include screening kits and Codex HiFi Hot Start DNA Polymerase. The company was founded in January 2002 and is headquartered in Redwood City, CA.

Codexis Inc.

Why Did CDXS Stock Jump 7% Today?

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

CDXSCodexis Inc.

Fundamentals

Latest CDXS News